SMITHS FALLS, Ont. - Canopy Growth Corp. has signed a deal to buy a German company that specializes in cannabinoid-based medical therapies used by European physicians for roughly $342.9 million. Under the deal, the Ontario-based company has acquired C3 Cannabinoid Compound Co.

Source: thestar May 02, 2019 11:26 UTC